ZA978220B - PTX-sensitive G proteins their preparation and use - Google Patents

PTX-sensitive G proteins their preparation and use

Info

Publication number
ZA978220B
ZA978220B ZA978220A ZA978220A ZA978220B ZA 978220 B ZA978220 B ZA 978220B ZA 978220 A ZA978220 A ZA 978220A ZA 978220 A ZA978220 A ZA 978220A ZA 978220 B ZA978220 B ZA 978220B
Authority
ZA
South Africa
Prior art keywords
ptx
proteins
sensitive
preparation
Prior art date
Application number
ZA978220A
Other languages
English (en)
Inventor
Winfried Siffert
Original Assignee
Winfried Siffert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winfried Siffert filed Critical Winfried Siffert
Publication of ZA978220B publication Critical patent/ZA978220B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
ZA978220A 1996-09-13 1997-09-12 PTX-sensitive G proteins their preparation and use ZA978220B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ZA978220B true ZA978220B (en) 1999-03-12

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA978220A ZA978220B (en) 1996-09-13 1997-09-12 PTX-sensitive G proteins their preparation and use

Country Status (22)

Country Link
US (1) US6251853B1 (fr)
EP (1) EP0931145A1 (fr)
JP (1) JP2001501811A (fr)
KR (1) KR20000036058A (fr)
CN (1) CN1230222A (fr)
AU (1) AU4619297A (fr)
BG (1) BG103238A (fr)
BR (1) BR9711475A (fr)
CA (1) CA2265467A1 (fr)
CZ (1) CZ73499A3 (fr)
DE (1) DE19637518A1 (fr)
EA (1) EA199900253A1 (fr)
EE (1) EE9900092A (fr)
HU (1) HUP9904110A3 (fr)
IL (1) IL128746A0 (fr)
IS (1) IS4987A (fr)
NO (1) NO991227L (fr)
PL (1) PL332417A1 (fr)
SK (1) SK34099A3 (fr)
TR (1) TR199900500T2 (fr)
WO (1) WO1998011212A1 (fr)
ZA (1) ZA978220B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
AU3975799A (en) * 1998-05-11 1999-11-29 Axys Pharmaceuticals, Inc. (rhoh) genes and their uses
AU6079999A (en) * 1998-09-10 2000-04-03 Winfried Siffert Gene modification in the gene for the die gbeta3-sub-unit of human g-protein
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
WO2001057246A1 (fr) * 2000-02-03 2001-08-09 Winfried Siffert UTILISATION D'UNE MODIFICATION GENETIQUE DANS LE GENE CODANT POUR LA SOUS-UNITE β3 DE LA PROTEINE G HUMAINE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
SK34099A3 (en) 2000-05-16
NO991227D0 (no) 1999-03-12
HUP9904110A2 (en) 2000-07-28
HUP9904110A3 (en) 2001-09-28
BG103238A (bg) 2000-06-30
CA2265467A1 (fr) 1998-03-19
PL332417A1 (en) 1999-09-13
TR199900500T2 (xx) 1999-06-21
CZ73499A3 (cs) 1999-07-14
IL128746A0 (en) 2000-01-31
BR9711475A (pt) 1999-08-24
EA199900253A1 (ru) 1999-10-28
DE19637518A1 (de) 1998-04-09
WO1998011212A1 (fr) 1998-03-19
AU4619297A (en) 1998-04-02
EP0931145A1 (fr) 1999-07-28
EE9900092A (et) 1999-10-15
KR20000036058A (ko) 2000-06-26
IS4987A (is) 1999-02-26
US6251853B1 (en) 2001-06-26
CN1230222A (zh) 1999-09-29
NO991227L (no) 1999-03-12
JP2001501811A (ja) 2001-02-13

Similar Documents

Publication Publication Date Title
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
EP0880356A4 (fr) Peptides antimicrobiens et procedes d'utilisation associes
ZA9711141B (en) Novel ketobenzamides and their use
IL130396A0 (en) OB fusion protein compositions and methods
IL125463A0 (en) Interleukin-18 binding proteins their preparation and use
IL123647A0 (en) Substituted amino compounds their preparation and use
GB9608130D0 (en) Adam proteins and uses thereof
ZA975202B (en) Plants proteins
ZA9710338B (en) Proteins
GB9516293D0 (en) Novel peptides and their use as vaccines
GB9614033D0 (en) Modified protein G and fragments thereof
ZA96240B (en) Novel peptides their preparation and use
ZA978220B (en) PTX-sensitive G proteins their preparation and use
ZA96239B (en) Novel peptides their preparation and use
GB9423372D0 (en) Proteins and their uses
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
PL328334A1 (en) Preparation and application thereof
GB2336844B (en) Anti-hiv peptides and proteins
AU4906597A (en) Human guanylate-binding proteins
IL130700A0 (en) Cyanophosphorus compounds and their preparation
AU5802798A (en) Human oncogene induced secreted protein i
EP0915100A4 (fr) Nouvelle proteine
ZA9710857B (en) Novel calpains their preparation and use
ZA971900B (en) Modified proteins
IL120392A0 (en) Novel PKA-binding proteins and uses thereof